Prudence A. Francis

Active 1993–2026

Also published as
Prudence A Francis
81
Papers
19,314
Citations
55
h-index
78
i10-index

Citations

Citations per year for Prudence A. Francis1971: 1 citations1993: 2 citations1995: 8 citations1996: 12 citations1997: 16 citations1998: 30 citations1999: 13 citations2000: 19 citations2001: 18 citations2002: 19 citations2003: 19 citations2004: 7 citations2005: 5 citations2006: 10 citations2007: 5 citations2008: 5 citations2009: 20 citations2010: 21 citations2011: 12 citations2012: 23 citations2013: 41 citations2014: 81 citations2015: 156 citations2016: 172 citations2017: 176 citations2018: 181 citations2019: 644 citations2020: 757 citations2021: 844 citations2022: 694 citations2023: 607 citations2024: 1,029 citations2025: 481 citations2026: 19 citations1972–1992: no citations, so these years are not shown1994: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,699 citing papers, 16.9% of this breakdownChina: 848 citing papers, 8.4% of this breakdownItaly: 754 citing papers, 7.5% of this breakdownUnited Kingdom: 521 citing papers, 5.2% of this breakdownGermany: 491 citing papers, 4.9% of this breakdownFrance: 474 citing papers, 4.7% of this breakdownAustralia: 415 citing papers, 4.1% of this breakdownSpain: 401 citing papers, 4% of this breakdownBelgium: 395 citing papers, 3.9% of this breakdownCanada: 340 citing papers, 3.4% of this breakdownSwitzerland: 321 citing papers, 3.2% of this breakdownJapan: 296 citing papers, 3% of this breakdown
0%16.9%Other 30.8%

Fields

  • Medicine60.4%
  • Biochemistry, Genetics and Molecular Biology30.8%
  • Immunology and Microbiology2.5%
  • Computer Science1.7%
  • Engineering1.3%
  • Materials Science0.8%
  • Other2.5%

Topics

  • Breast Cancer Treatment Studies10.2%
  • Advanced Breast Cancer Therapies6.8%
  • Cancer Immunotherapy and Biomarkers6.2%
  • HER2/EGFR in Cancer Research5.1%
  • Cancer Treatment and Pharmacology3.2%
  • Immunotherapy and Immune Responses2.8%
  • Other65.7%

Coauthors

All papers

Open in search
  1. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph A. Sparano, Tanja Španić, Sandra M. Swain, Sergei Tjulandin, Masakazu Toi, Dario Trapani, Andrew Tutt, B. Xu, Giuseppe Curigliano, Nadia Harbeck - Annals of Oncology 2023 cited by 844

  2. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Silvia P. Neciosup, B.V. Offersen, Shinji Ohno, Olivia Pagani, A. Prat, Frédérique Penault‐Llorca, Hope S. Rugo, G. W. Sledge, Christoph Thomssen, D.A. Vorobiof, Theresa Wiseman, Binghe Xu, Larry Norton, A. Costa, Eric P. Winer - Annals of Oncology 2020 cited by 1,356

  3. 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Efthymios Papadopoulos, Fedro A. Peccatori, Frédérique Penault‐Llorca, Martine Piccart, Jean‐Yves Pierga, Hope S. Rugo, Lillie D. Shockney, George W. Sledge, Sandra M. Swain, Christoph Thomssen, Andrew Tutt, Daniel Vorobiof, Binghe Xu, Larry Norton, Eric P. Winer - Annals of Oncology 2016 cited by 2,062

  4. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Viviana Galimberti, Hebatallah Gamal El Din Mohamed Mahmoud, Judy E. Garber, Michael Gnant, William J. Gradishar, Bahadır M. Güllüoğlu, Nadia Harbeck, Chiun‐Sheng Huang, Jens Huober, André Ilbawi, Zefei Jiang, Steven Johnston, Eun Sook Lee, Sibylle Loibl, Monica Morrow, Ann H. Partridge, Martine Piccart, Philip Poortmans, Aleix Prat, Meredith M. Regan, Isabella Rubio, Hope S. Rugo, Emiel J. Rutgers, Felix Sedlmayer, Vladimir Semiglazov, Hans-Joerg Senn, Zhiming Shao, Tanja Španić, Petra Tesařová, Beat Thürlimann, Sergei Tjulandin, Masakazu Toi, Maureen Trudeau, Nicholas Turner, Inez Vaz Luis, Giuseppe Viale, Toru Watanabe, William P. Weber, Eric P. Winer, Binghe Xu - Annals of Oncology 2021 cited by 803

  5. Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 891

  6. Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2013 cited by 1,647

  7. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simon Read, Ewan Straiton, Raimund Jakesz, Christian Fesl, Olivia Pagani, Richard Gelber, Michelino De Laurentiis, Sabino De Placido, Ciro Gallo, Kathy Albain, Stewart Anderson, Rodrigo Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith Bliss, Etienne Brain, Lisa Carey, Robert Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Matthew Goetz, Pam Goodwin, Pat Halpin-Murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Kathleen I Pritchard, Vinod Raina, Daniel Rea, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Sandra M Swain - The Lancet Oncology 2022 cited by 299

  8. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Isabel Frahm, Joselyn Sanchez, Miluska Castillo, Najat Bouchmaa, Reena R. Md Zin, Ruohong Shui, Timothy Onyuma, Wentao Yang, Zaheed Husain, Karen Willard‐Gallo, An Coosemans, Edith Perez, Elena Provenzano, Paula Gonzalez Ericsson, Eduardo Richardet, Ravi Mehrotra, Sandra Sarancone, Anna Ehinger, David L. Rimm, John M.S. Bartlett, Giuseppe Viale, Carsten Denkert, Akira I. Hida, Christos Sotiriou, Sibylle Loibl, Stephen M. Hewitt, Sunil Badve, W. Fraser Symmans, Rim S. Kim, Giancarlo Pruneri, Shom Goel, Prudence A. Francis, Gloria Inurrigarro, Rin Yamaguchi, Hernán Garcı́a Rivello, Hugo M. Horlings, Saïd Afqir, Roberto Salgado, Sylvia Adams, Marleen Kok, Maria Vittoria Dieci, Stefan Michiels, Sandra Demaria, Sherene Loi, The International Immuno-Oncology Biomarker Working Group, Khalid El Bairi, Harry R. Haynes, Elizabeth F. Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner, Juliana Ribeiro de Freitas, Daniel Sur, Luis Claudio Amendola, Masoumeh Gharib, Amine Kallala, Indu Arun, Farid Azmoudeh-Ardalan, Luciana Botinelly Mendonça Fujimoto, Luz F. Sua, Shiwei Liu, Huang‐Chun Lien, Pawan Kirtani, Marcelo Balancin, Hicham El Attar, Prerna Guleria, Wenxian Yang, Emad Shash, I‐Chun Chen, Veronica Bautista and 454 more - npj Breast Cancer 2021 cited by 275

  9. openalex_id:w4226348827

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simon Read, Ewan Straiton, R. Jakesz, Christian Fesl, Olivia Pagani, Richard D. Gelber, Michelino De Laurentiis, Sabino De Placido, Ciro Gallo, Kathy S. Albain, Stewart Anderson, R. Arriagada, John M.S. Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa A. Carey, Robert E. Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Matthew Goetz, Pam Goodwin, Pat Halpin-murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Kathleen I Pritchard, Vinod Raina, Daniel Rea, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Sandra M Swain cited by 223

  10. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giuseppe Curigliano, Jana de Boniface, Suzette Delaloge, A. DeMichele, Carsten Denkert, Gerd Fastner, Florian Fitzal, Prudence A. Francis, H Gamal, Oreste ­Gentilini, Michael Gnant, William J. Gradishar, B. Gulluoglu, Nadia Harbeck, Jörg Heil, Chien Shiun Huang, Jens Huober, Zeping Jiang, Orit Kaidar‐Person, Marleen Kok, Eun‐So Lee, Sherene Loi, S. Loibl, Miguel Martín, Icro Meattini, Monica Morrow, A. H. Partridge, Frédérique Penault‐Llorca, Martine Piccart, Lori J. Pierce, Philip Poortmans, Meredith M. Regan, J. S. Reis-Filho, Isabel T. Rubio, Hope S. Rugo, Emiel J. Rutgers, Cristina Saura, Elżbieta Senkus, Zhi-Ming Shao, Christian F. Singer, Tanja Španič, Beat Thuerlimann, Masakazu Toi, Sara M. Tolaney, Nicholas C. Turner, Andrew Tutt, M.-J. Vrancken Peeters, Toru Watanabe, William P. Weber, Hans Wildiers, B. Xu - Annals of Oncology 2023 cited by 221

  11. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chiun‐Sheng Huang, Jens Huober, Hussein Khaled, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, Kent C. Osborne, Olivia Pagani, Ann H. Partridge, K. Pritchard, Jungsil Ro, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Toru Watanabe, Timothy J. Whelan, Binghe Xu - Annals of Oncology 2017 cited by 1,255

  12. The Lancet Breast Cancer Commission

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dingle Spence, Hilary Stobart, Valentina Vargas Enciso, Inês Vaz-Luís, Cynthia Villarreal‐Garza, Héctor Arreola‐Ornelas, Afsan Bhadelia, Judy C. Boughey, Sanjoy Chatterjee, David Dodwell, Svetlana V. Doubova, Dorothy Du Plooy, Beverley M. Essue, Neha Goel, Julie R. Gralow, Sarah T. Hawley, Belinda E. Kiely, Ritse M. Mann, Shirley Mertz, Carlo Palmieri, Philip Poortmans, Tanja Španić, Lesley Stephen, Fraser Symmans, Catherine Towns, Didier Verhoeven, Sarah Vinnicombe, David Watkins, Cheng Har Yip, Brian J. Zikmund‐Fisher - The Lancet 2024 cited by 154

  13. Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barbara Ruepp, Angelo Di Leo, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Meredith M. Regan - New England Journal of Medicine 2018 cited by 673

  14. Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 154

  15. 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Belinda E. Kiely, Sungbae Kim, Smruti Koppikar, Marion Kuper‐Hommel, Frédéric Lecouvet, Ginny Mason, Shirley Mertz, Volkmar Müller, Claire Myerson, Silvia P. Neciosup, Birgitte Vrou Offersen, Shinji Ohno, Olivia Pagani, Ann H. Partridge, Frédérique Penault‐Llorca, Aleix Prat, Hope S. Rugo, Elżbieta Senkus, George W. Sledge, Sandra M. Swain, Christoph Thomssen, Daniel Vorobiof, Peter Vuylsteke, Theresa Wiseman, Binghe Xu, Alberto Costa, Larry Norton, Eric P. Winer - The Breast 2024 cited by 197

  16. Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard D. Gelber, Aron Goldhirsch, Prudence A. Francis - New England Journal of Medicine 2014 cited by 747

  17. Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - npj Breast Cancer 2022 cited by 78

  18. Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 727

  19. Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study

    Authors: , , , , , , , , , , , , , , , , , , - Cancer Discovery 2022 cited by 55

  20. Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 cited by 542

  21. Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 150

  22. Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 58

  23. Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 148

  24. Differential Benefit of Adjuvant Docetaxel-Based Chemotherapy in Patients With Early Breast Cancer According to Baseline Body Mass Index

    Authors: , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 60